ArticleCell communication and signaling : CCS2026
Circadian rhythm of dendritic cells directs the time-dependent efficacy of photodynamic therapy.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWhile cancer treatment efficacy exhibits circadian differences, the role of circadian rhythms in photodynamic therapy (PDT) remains unclear. Understanding this relationship is crucial for treatment optimization.
methodsUsing B16F10 and 4T1 tumor-bearing mice, PDT was administered at different Zeitgeber times (ZT). Immune cell infiltration was analyzed using flow cytometry and immunofluorescence. We also compared the effects of PDT treatment between NSG mice and CD11c-DTR mice. Transcriptomic profiling of sorted CD11c⁺MHCII⁺ DCs was performed via RNA-seq. In vitro assays measured immunogenic cell death (ICD) markers and dendritic cells (DC) maturation. A PDT vaccine model was also evaluated.
resultsPDT efficacy showed strong circadian dependence, optimal at ZT10 and weakest at ZT22 in immunocompetent mice-a rhythm maintained in constant darkness but inverted with light-cycle reversal, confirming endogenous control. The effect was abrogated in immunodeficient NSG mice, pinpointing an immune-mediated mechanism. Further analysis revealed circadian oscillations in the infiltration of CD4⁺, and CD8⁺ T cells into tumors and spleens, peaking at ZT10. Crucially, the rhythmic abundance and function of CD11c⁺MHCII⁺ DCs were identified as the pivotal regulator. Specific DC ablation eliminated both the circadian efficacy of PDT and the rhythmic T-cell infiltration. Transcriptomics revealed ZT10 DCs were polarized toward adaptive immunity, while ZT22 DCs favored pro-tumorigenic pathways. PDT-induced ICD promoted DC maturation in vitro and enhanced antitumor responses in vivo.
conclusionThe intrinsic circadian rhythm of DCs is a master regulator of PDT efficacy, rhythmically governing adaptive antitumor immunity. These findings advocate chrono-immunotherapy through precise treatment timing to maximize clinical benefits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.